Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Helen Torley. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Helen Torley zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:HALO / Halozyme Therapeutics, Inc. | PRESIDENT AND CEO, Director | 767 780 |
| US:DGX / Quest Diagnostics Incorporated | Director | 6 260 |
| US:RLYP / Relypsa, Inc. | Director | 0 |
| US:ONXX / Onyx Pharmaceuticals Inc | EVP, Chief Commercial Officer | 0 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Helen Torley. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Zakupy insidera HALO / Halozyme Therapeutics, Inc. – krótkoterminowa analiza zysków
W tej części analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w HALO / Halozyme Therapeutics, Inc.. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do maks |
Cena maks |
Maks Zysk ($) |
Maksymalny zwrot (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-09-16 | HALO | Torley Helen | 50 000 | 8,9200 | 50 000 | 8,9200 | 446 000 | 309 | 24.7500 | 791 500 | 177,47 |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Sprzedaż insidera HALO / Halozyme Therapeutics, Inc. — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży poufnych informacji na otwartym rynku dokonanej w HALO / Halozyme Therapeutics, Inc.. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Helen Torley ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -6 100 | 767 780 | -0,79 | 69,69 | -425 121 | 53 508 124 |
| 2026-06-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -2 000 | 773 880 | -0,26 | 68,74 | -137 472 | 53 193 416 |
| 2026-06-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -1 500 | 775 880 | -0,19 | 67,68 | -101 512 | 52 507 679 |
| 2026-06-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -400 | 777 380 | -0,05 | 66,37 | -26 547 | 51 593 156 |
| 2026-06-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 777 780 | 1,30 | 12,07 | 120 700 | 9 387 805 |
| 2026-06-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -3 400 | 767 780 | -0,44 | 66,74 | -226 933 | 51 245 476 |
| 2026-06-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -16 600 | 771 180 | -2,11 | 66,31 | -1 100 812 | 51 140 031 |
| 2026-06-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 787 780 | 2,60 | 12,07 | 241 400 | 9 508 505 |
| 2026-06-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -5 401 | 767 780 | -0,70 | 68,35 | -369 137 | 52 474 692 |
| 2026-06-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -12 989 | 773 181 | -1,65 | 67,41 | -875 588 | 52 120 131 |
| 2026-06-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -1 610 | 786 170 | -0,20 | 66,39 | -106 885 | 52 192 254 |
| 2026-06-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 787 780 | 2,60 | 12,07 | 241 400 | 9 508 505 |
| 2026-05-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -600 | 767 780 | -0,08 | 70,81 | -42 487 | 54 368 037 |
| 2026-05-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -3 950 | 768 380 | -0,51 | 69,79 | -275 659 | 53 622 935 |
| 2026-05-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -3 350 | 772 330 | -0,43 | 68,88 | -230 748 | 53 198 090 |
| 2026-05-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -2 100 | 775 680 | -0,27 | 68,10 | -143 014 | 52 825 359 |
| 2026-05-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 10 000 | 777 780 | 1,30 | 12,07 | 120 700 | 9 387 805 | |
| 2026-05-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -2 800 | 767 780 | -0,36 | 73,12 | -204 739 | 56 140 841 |
| 2026-05-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -5 900 | 770 580 | -0,76 | 72,15 | -425 673 | 55 595 806 |
| 2026-05-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -9 802 | 776 480 | -1,25 | 71,37 | -699 569 | 55 417 378 |
| 2026-05-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -1 398 | 786 282 | -0,18 | 70,29 | -98 261 | 55 265 403 |
| 2026-05-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -100 | 787 680 | -0,01 | 67,85 | -6 785 | 53 444 088 |
| 2026-05-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 787 780 | 2,60 | 12,07 | 241 400 | 9 508 505 |
| 2026-05-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -6 700 | 767 780 | -0,87 | 66,33 | -444 391 | 50 924 544 |
| 2026-05-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -3 575 | 774 480 | -0,46 | 65,46 | -234 012 | 50 695 912 |
| 2026-05-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -9 725 | 778 055 | -1,23 | 64,63 | -628 536 | 50 286 473 |
| 2026-05-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 787 780 | 2,60 | 12,07 | 241 400 | 9 508 505 |
| 2026-04-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -4 100 | 767 780 | -0,53 | 64,02 | -262 462 | 49 149 437 |
| 2026-04-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -5 900 | 771 880 | -0,76 | 63,14 | -372 520 | 48 735 731 |
| 2026-04-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 777 780 | 1,30 | 12,07 | 120 700 | 9 387 805 |
| 2026-04-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -4 200 | 767 780 | -0,54 | 64,89 | -272 525 | 49 818 941 |
| 2026-04-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -15 800 | 771 980 | -2,01 | 64,06 | -1 012 195 | 49 455 355 |
| 2026-04-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 787 780 | 2,60 | 12,07 | 241 400 | 9 508 505 |
| 2026-04-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -1 000 | 767 780 | -0,13 | 65,71 | -65 714 | 50 453 895 |
| 2026-04-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -19 000 | 768 780 | -2,41 | 65,36 | -1 241 802 | 50 245 923 |
| 2026-04-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 787 780 | 2,60 | 12,07 | 241 400 | 9 508 505 |
| 2026-03-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -2 671 | 767 780 | -0,35 | 70,94 | -189 494 | 54 470 152 |
| 2026-03-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -7 329 | 770 451 | -0,94 | 69,94 | -512 620 | 53 888 425 |
| 2026-03-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 777 780 | 1,30 | 12,07 | 120 700 | 9 387 805 |
| 2026-03-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -6 519 | 767 780 | -0,84 | 69,33 | -451 982 | 53 232 491 |
| 2026-03-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -13 481 | 774 299 | -1,71 | 68,85 | -928 167 | 53 310 486 |
| 2026-03-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 787 780 | 2,60 | 12,07 | 241 400 | 9 508 505 |
| 2026-03-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -578 | 767 780 | -0,08 | 70,46 | -40 726 | 54 098 547 |
| 2026-03-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -15 322 | 768 358 | -1,96 | 69,80 | -1 069 460 | 53 630 620 |
| 2026-03-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -4 100 | 783 680 | -0,52 | 69,20 | -283 708 | 54 228 305 |
| 2026-03-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 787 780 | 2,60 | 12,07 | 241 400 | 9 508 505 |
| 2026-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -12 104 | 767 780 | -1,55 | 70,64 | -855 027 | 54 235 979 | |
| 2026-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 22 436 | 779 884 | 2,96 | ||||
| 2026-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -9 040 | 757 448 | -1,18 | 70,98 | -641 659 | 53 763 659 | |
| 2026-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 16 757 | 766 488 | 2,24 | ||||
| 2026-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -27 605 | 749 731 | -3,55 | 79,44 | -2 192 941 | 59 558 631 | |
| 2026-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 51 171 | 777 336 | 7,05 | ||||
| 2026-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -9 104 | 726 165 | -1,24 | 79,44 | -723 222 | 57 686 548 | |
| 2026-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 16 875 | 735 269 | 2,35 | ||||
| 2026-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -11 334 | 718 394 | -1,55 | 79,44 | -900 373 | 57 069 219 | |
| 2026-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 21 009 | 729 728 | 2,96 | ||||
| 2026-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -4 624 | 708 719 | -0,65 | 78,94 | -365 000 | 55 943 443 |
| 2026-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -5 376 | 713 343 | -0,75 | 78,38 | -421 366 | 55 911 111 |
| 2026-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 718 719 | 1,41 | 12,07 | 120 700 | 8 674 938 |
| 2026-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 100 | 708 719 | -1,41 | 77,54 | -783 154 | 54 954 071 |
| 2026-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -9 900 | 718 819 | -1,36 | 76,94 | -761 666 | 55 303 059 |
| 2026-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 728 719 | 2,82 | 12,07 | 241 400 | 8 795 638 |
| 2026-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -7 790 | 708 719 | -1,09 | 76,73 | -597 758 | 54 382 844 |
| 2026-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -9 659 | 716 509 | -1,33 | 75,94 | -733 543 | 54 414 559 |
| 2026-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -2 551 | 726 168 | -0,35 | 74,88 | -191 016 | 54 374 734 |
| 2026-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 728 719 | 2,82 | 12,07 | 241 400 | 8 795 638 |
| 2025-12-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -261 | 708 719 | -0,04 | 71,60 | -18 688 | 50 744 280 |
| 2025-12-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -500 | 708 980 | -0,07 | 70,36 | -35 181 | 49 885 251 |
| 2025-12-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -5 402 | 709 480 | -0,76 | 69,44 | -375 120 | 49 267 001 |
| 2025-12-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 406 | 714 882 | -1,43 | 68,51 | -712 936 | 48 977 996 |
| 2025-12-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 16 569 | 725 288 | 2,34 | 8,11 | 134 375 | 5 882 086 |
| 2025-12-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
G - Gift | -25 000 | 708 719 | -3,41 | ||||
| 2025-11-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -498 | 733 719 | -0,07 | 71,67 | -35 690 | 52 583 440 |
| 2025-11-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -6 784 | 734 217 | -0,92 | 71,09 | -482 268 | 52 194 752 |
| 2025-11-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -12 718 | 741 001 | -1,69 | 70,22 | -893 033 | 52 031 608 |
| 2025-11-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
| 2025-11-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -11 500 | 733 719 | -1,54 | 69,73 | -801 906 | 51 162 960 |
| 2025-11-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -4 000 | 745 219 | -0,53 | 68,80 | -275 180 | 51 267 341 |
| 2025-11-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -4 500 | 749 219 | -0,60 | 67,89 | -305 514 | 50 865 976 |
| 2025-11-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
| 2025-11-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -100 | 733 719 | -0,01 | 69,30 | -6 930 | 50 846 727 |
| 2025-11-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -19 900 | 733 819 | -2,64 | 68,71 | -1 367 409 | 50 423 639 |
| 2025-11-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
| 2025-10-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -724 | 733 719 | -0,10 | 71,67 | -51 891 | 52 587 108 |
| 2025-10-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -2 707 | 734 443 | -0,37 | 70,58 | -191 065 | 51 838 456 |
| 2025-10-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -2 334 | 737 150 | -0,32 | 69,83 | -162 983 | 51 475 184 |
| 2025-10-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -14 235 | 739 484 | -1,89 | 68,47 | -974 699 | 50 633 948 |
| 2025-10-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
| 2025-10-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -100 | 733 719 | -0,01 | 74,66 | -7 466 | 54 783 129 |
| 2025-10-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -700 | 733 819 | -0,10 | 73,24 | -51 265 | 53 741 968 |
| 2025-10-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -2 400 | 734 519 | -0,33 | 72,06 | -172 956 | 52 933 112 |
| 2025-10-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 200 | 736 919 | -1,37 | 71,28 | -727 036 | 52 526 112 |
| 2025-10-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -6 600 | 747 119 | -0,88 | 70,51 | -465 359 | 52 678 614 |
| 2025-10-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
| 2025-10-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -8 295 | 733 719 | -1,12 | 75,69 | -627 873 | 55 537 392 |
| 2025-10-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -11 705 | 742 014 | -1,55 | 75,11 | -879 151 | 55 731 930 |
| 2025-10-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
| 2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -2 300 | 733 719 | -0,31 | 75,22 | -173 015 | 55 193 278 |
| 2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -7 800 | 736 019 | -1,05 | 74,33 | -579 751 | 54 706 084 |
| 2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -9 900 | 743 819 | -1,31 | 73,54 | -728 006 | 54 697 474 |
| 2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
| 2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 500 | 733 719 | -1,41 | 74,63 | -783 636 | 54 758 916 |
| 2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -9 500 | 744 219 | -1,26 | 74,22 | -705 090 | 55 235 934 |
| 2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
| 2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -3 412 | 733 719 | -0,46 | 74,15 | -252 990 | 54 403 063 |
| 2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -16 288 | 737 131 | -2,16 | 73,70 | -1 200 393 | 54 325 080 |
| 2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -300 | 753 419 | -0,04 | 72,48 | -21 746 | 54 611 576 |
| 2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
| 2025-08-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -5 052 | 733 719 | -0,68 | 64,83 | -327 511 | 47 565 535 |
| 2025-08-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -14 948 | 738 771 | -1,98 | 64,14 | -958 839 | 47 388 466 |
| 2025-08-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
| 2025-08-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -6 958 | 733 719 | -0,94 | 64,00 | -445 319 | 46 958 750 |
| 2025-08-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -13 042 | 740 677 | -1,73 | 63,24 | -824 802 | 46 841 895 |
| 2025-08-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
| 2025-08-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -1 283 | 733 719 | -0,17 | 63,60 | -81 596 | 46 663 061 |
| 2025-08-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -18 717 | 735 002 | -2,48 | 63,01 | -1 179 321 | 46 311 006 |
| 2025-08-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
| 2025-07-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -15 746 | 733 719 | -2,10 | 57,62 | -907 237 | 42 274 688 |
| 2025-07-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -4 254 | 749 465 | -0,56 | 56,74 | -241 380 | 42 526 143 |
| 2025-07-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
| 2025-07-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -208 | 733 719 | -0,03 | 57,08 | -11 872 | 41 877 746 |
| 2025-07-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -19 792 | 733 927 | -2,63 | 56,43 | -1 116 783 | 41 412 565 |
| 2025-07-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
| 2025-07-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -16 402 | 733 719 | -2,19 | 55,74 | -914 215 | 40 896 030 |
| 2025-07-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -3 598 | 750 121 | -0,48 | 54,48 | -196 030 | 40 868 842 |
| 2025-07-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
| 2025-06-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -15 511 | 733 719 | -2,07 | 53,91 | -836 214 | 39 555 525 |
| 2025-06-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -4 489 | 749 230 | -0,60 | 53,11 | -238 406 | 39 790 856 |
| 2025-06-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
| 2025-06-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -20 000 | 733 719 | -2,65 | 52,57 | -1 051 460 | 38 573 809 |
| 2025-06-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
| 2025-06-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -20 000 | 733 719 | -2,65 | 52,96 | -1 059 200 | 38 857 758 |
| 2025-06-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
| 2025-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -12 081 | 733 719 | -1,62 | 57,75 | -697 678 | 42 372 272 | |
| 2025-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 22 436 | 745 800 | 3,10 | ||||
| 2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -9 087 | 723 364 | -1,24 | 58,29 | -529 681 | 42 164 888 | |
| 2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 16 875 | 732 451 | 2,36 | ||||
| 2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -11 313 | 715 576 | -1,56 | 58,29 | -659 435 | 41 710 925 | |
| 2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 21 009 | 726 889 | 2,98 | ||||
| 2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -38 668 | 705 880 | -5,19 | 58,29 | -2 253 958 | 41 145 745 | |
| 2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 71 810 | 744 548 | 10,67 | ||||
| 2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -7 098 | 672 738 | -1,04 | 58,29 | -413 742 | 39 213 898 | |
| 2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 13 092 | 679 836 | 1,96 | ||||
| 2024-12-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
G - Gift | -10 000 | 666 744 | -1,48 | ||||
| 2024-10-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -2 404 | 676 744 | -0,35 | 53,91 | -129 590 | 36 480 562 |
| 2024-10-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -1 615 | 679 148 | -0,24 | 53,31 | -86 096 | 36 205 380 |
| 2024-10-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -5 981 | 680 763 | -0,87 | 51,85 | -310 097 | 35 295 519 |
| 2024-10-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
| 2024-10-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -900 | 676 744 | -0,13 | 54,57 | -49 116 | 36 931 950 |
| 2024-10-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -9 100 | 677 644 | -1,33 | 53,94 | -490 845 | 36 551 440 |
| 2024-10-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
| 2024-09-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 676 744 | -1,46 | 56,10 | -560 970 | 37 963 308 |
| 2024-09-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
| 2024-09-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 676 744 | -1,46 | 56,34 | -563 370 | 38 125 727 |
| 2024-09-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
| 2024-09-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 676 744 | -1,46 | 58,21 | -582 100 | 39 393 268 |
| 2024-09-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
| 2024-09-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 676 744 | -1,46 | 59,20 | -592 030 | 40 065 275 |
| 2024-09-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
| 2024-09-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 676 744 | -1,46 | 59,09 | -590 870 | 39 986 773 |
| 2024-09-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
| 2024-09-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 676 744 | -1,46 | 59,09 | -590 890 | 39 988 126 |
| 2024-09-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
| 2024-08-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 676 744 | -1,46 | 57,95 | -579 490 | 39 216 638 |
| 2024-08-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
| 2024-08-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -200 | 676 744 | -0,03 | 58,17 | -11 634 | 39 366 198 |
| 2024-08-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -6 537 | 676 944 | -0,96 | 57,73 | -377 394 | 39 081 331 |
| 2024-08-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -3 263 | 683 481 | -0,48 | 56,22 | -183 443 | 38 424 618 |
| 2024-08-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
| 2024-08-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 676 744 | -1,46 | 56,25 | -562 490 | 38 066 173 |
| 2024-08-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
| 2024-02-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -9 070 | 676 744 | -1,32 | 36,10 | -327 427 | 24 430 458 | |
| 2024-02-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 16 875 | 685 814 | 2,52 | ||||
| 2024-02-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -11 292 | 668 939 | -1,66 | 36,10 | -407 641 | 24 148 698 | |
| 2024-02-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 21 009 | 680 231 | 3,19 | ||||
| 2024-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -17 619 | 659 222 | -2,60 | 35,91 | -632 698 | 23 672 662 | |
| 2024-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
A - Award | 32 781 | 676 841 | 5,09 | ||||
| 2024-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -7 036 | 644 060 | -1,08 | 35,91 | -252 663 | 23 128 195 | |
| 2024-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 13 092 | 651 096 | 2,05 | ||||
| 2024-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -16 943 | 638 004 | -2,59 | 35,49 | -601 307 | 22 642 762 | |
| 2024-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 31 281 | 654 947 | 5,02 | ||||
| 2023-08-31 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 623 666 | -1,58 | 42,82 | -428 170 | 26 703 507 |
| 2023-08-31 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 13,87 | 138 700 | 8 788 947 |
| 2023-08-31 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 623 666 | -1,58 | 42,85 | -428 540 | 26 726 583 |
| 2023-08-31 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 13,87 | 138 700 | 8 788 947 |
| 2023-08-31 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 623 666 | -1,58 | 42,40 | -424 020 | 26 444 686 |
| 2023-08-31 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 13,87 | 138 700 | 8 788 947 |
| 2023-08-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 623 666 | -1,58 | 43,18 | -431 820 | 26 931 145 |
| 2023-08-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 13,87 | 138 700 | 8 788 947 |
| 2023-08-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 623 666 | -1,58 | 43,53 | -435 320 | 27 149 428 |
| 2023-08-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 13,87 | 138 700 | 8 788 947 |
| 2023-08-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 623 666 | -1,58 | 43,77 | -437 680 | 27 296 613 |
| 2023-08-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 13,87 | 138 700 | 8 788 947 |
| 2023-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 623 666 | -1,58 | 43,79 | -437 900 | 27 310 334 |
| 2023-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 13,87 | 138 700 | 8 788 947 |
| 2023-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 623 666 | -1,58 | 42,69 | -426 890 | 26 623 678 |
| 2023-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 13,87 | 138 700 | 8 788 947 |
| 2023-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 623 666 | -1,58 | 42,80 | -427 960 | 26 690 410 |
| 2023-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 13,87 | 138 700 | 8 788 947 |
| 2023-03-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 623 666 | -1,58 | 42,73 | -427 270 | 26 647 377 |
| 2023-03-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 14,66 | 146 600 | 9 289 544 |
| 2023-03-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 623 666 | -1,58 | 43,26 | -432 590 | 26 979 167 |
| 2023-03-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 14,66 | 146 600 | 9 289 544 |
| 2023-03-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 623 666 | -1,58 | 45,47 | -454 690 | 28 357 469 |
| 2023-03-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 14,66 | 146 600 | 9 289 544 |
| 2023-03-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
G - Gift | -10 000 | 623 666 | -1,58 | ||||
| 2023-02-21 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | -11 061 | 633 666 | -1,72 | 49,26 | -544 865 | 31 214 387 | |
| 2023-02-21 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 21 010 | 644 727 | 3,37 | ||||
| 2023-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -6 892 | 623 717 | -1,09 | 49,20 | -339 086 | 30 686 876 | |
| 2023-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 13 092 | 630 609 | 2,12 | ||||
| 2023-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -17 266 | 617 517 | -2,72 | 48,92 | -844 653 | 30 208 932 | |
| 2023-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 32 794 | 634 783 | 5,45 | ||||
| 2023-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -16 469 | 601 989 | -2,66 | 48,92 | -805 663 | 29 449 302 | |
| 2023-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 31 281 | 618 458 | 5,33 | ||||
| 2023-02-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 587 177 | -1,67 | 50,40 | -504 000 | 29 593 721 |
| 2023-02-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
| 2023-02-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 587 177 | -1,67 | 51,36 | -513 570 | 30 155 649 |
| 2023-02-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
| 2023-02-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 587 177 | -1,67 | 51,26 | -512 580 | 30 097 519 |
| 2023-02-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
| 2023-01-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 587 177 | -1,67 | 52,41 | -524 140 | 30 776 295 |
| 2023-01-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
| 2023-01-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 587 177 | -1,67 | 51,05 | -510 470 | 29 973 624 |
| 2023-01-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
| 2023-01-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -1 103 | 587 177 | -0,19 | 50,93 | -56 175 | 29 904 337 |
| 2023-01-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -8 897 | 588 280 | -1,49 | 50,40 | -448 364 | 29 646 371 |
| 2023-01-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
| 2022-12-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -896 | 587 177 | -0,15 | 58,20 | -52 145 | 34 171 940 |
| 2022-12-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -9 104 | 588 073 | -1,52 | 57,29 | -521 550 | 33 689 526 |
| 2022-12-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
| 2022-12-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 587 177 | -1,67 | 58,30 | -582 980 | 34 231 245 |
| 2022-12-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
| 2022-12-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -493 | 587 177 | -0,08 | 59,12 | -29 146 | 34 713 904 |
| 2022-12-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -9 507 | 587 670 | -1,59 | 58,64 | -557 481 | 34 460 381 |
| 2022-12-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
| 2022-11-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 587 177 | -1,67 | 52,15 | -521 490 | 30 620 693 |
| 2022-11-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
| 2022-11-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -10 000 | 587 177 | -1,67 | 53,90 | -538 990 | 31 648 253 |
| 2022-11-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
| 2022-11-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -13 | 587 177 | 0,00 | 54,60 | -710 | 32 062 800 |
| 2022-11-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -9 987 | 587 190 | -1,67 | 54,11 | -540 437 | 31 775 200 |
| 2022-11-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
| 2022-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
A - Award | 84 037 | 84 037 | |||||
| 2022-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
A - Award | 257 046 | 257 046 | |||||
| 2022-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | -13 092 | 39 276 | -25,00 | ||||
| 2022-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -6 892 | 587 177 | -1,16 | 34,43 | -237 292 | 20 216 504 | |
| 2022-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 13 092 | 594 069 | 2,25 | ||||
| 2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | -28 729 | 0 | -100,00 | ||||
| 2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -15 125 | 580 977 | -2,54 | 33,64 | -508 805 | 19 544 066 | |
| 2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 28 729 | 596 102 | 5,06 | ||||
| 2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | -32 795 | 32 794 | -50,00 | ||||
| 2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -17 266 | 567 373 | -2,95 | 34,20 | -590 497 | 19 404 157 | |
| 2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 32 795 | 584 639 | 5,94 | ||||
| 2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | -31 282 | 62 562 | -33,33 | ||||
| 2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -16 598 | 551 844 | -2,92 | 34,94 | -579 934 | 19 281 429 | |
| 2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 31 282 | 568 442 | 5,82 | ||||
| 2021-11-08 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | X | -50 000 | 150 000 | -25,00 | 14,66 | -733 000 | 2 199 000 |
| 2021-11-08 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -12 225 | 537 160 | -2,23 | 40,42 | -494 122 | 21 711 470 |
| 2021-11-08 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -37 775 | 549 385 | -6,43 | 39,62 | -1 496 646 | 21 766 634 |
| 2021-11-08 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 587 160 | 9,31 | 14,66 | 733 000 | 8 607 766 |
| 2021-10-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | X | -50 000 | 200 000 | -20,00 | 14,66 | -733 000 | 2 932 000 |
| 2021-10-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -5 857 | 537 160 | -1,08 | 40,95 | -239 862 | 21 998 313 |
| 2021-10-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -44 143 | 543 017 | -7,52 | 39,97 | -1 764 528 | 21 706 019 |
| 2021-10-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 587 160 | 9,31 | 14,66 | 733 000 | 8 607 766 |
| 2021-09-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | X | -50 000 | 250 000 | -16,67 | 14,66 | -733 000 | 3 665 000 |
| 2021-09-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -6 560 | 537 160 | -1,21 | 42,98 | -281 942 | 23 086 600 |
| 2021-09-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -43 440 | 543 720 | -7,40 | 42,29 | -1 836 904 | 22 991 744 |
| 2021-09-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 587 160 | 9,31 | 14,66 | 733 000 | 8 607 766 |
| 2021-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | X | -50 000 | 300 000 | -14,29 | 14,66 | -733 000 | 4 398 000 |
| 2021-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -1 048 | 537 160 | -0,19 | 46,11 | -48 323 | 24 768 448 |
| 2021-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -500 | 538 208 | -0,09 | 44,91 | -22 454 | 24 169 845 |
| 2021-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -400 | 538 708 | -0,07 | 43,26 | -17 304 | 23 304 508 |
| 2021-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -1 000 | 539 108 | -0,19 | 42,64 | -42 640 | 22 987 565 |
| 2021-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -21 914 | 540 108 | -3,90 | 41,47 | -908 752 | 22 397 739 |
| 2021-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -25 138 | 562 022 | -4,28 | 40,42 | -1 016 103 | 22 717 491 |
| 2021-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 587 160 | 9,31 | 14,66 | 733 000 | 8 607 766 |
| 2021-07-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | -50 000 | 350 000 | -12,50 | 14,66 | -733 000 | 5 131 000 | |
| 2021-07-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -50 000 | 537 160 | -8,52 | 45,97 | -2 298 650 | 24 694 857 |
| 2021-07-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 587 160 | 9,31 | 14,66 | 733 000 | 8 607 766 |
| 2021-06-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | -50 000 | 400 000 | -11,11 | 14,66 | -733 000 | 5 864 000 | |
| 2021-06-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -50 000 | 537 160 | -8,52 | 39,66 | -1 982 950 | 21 303 228 |
| 2021-06-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 587 160 | 9,31 | 14,66 | 733 000 | 8 607 766 |
| 2021-05-25 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
A - Award | 1 363 | 6 260 | 27,83 | ||||
| 2021-05-11 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | -50 000 | 450 000 | -10,00 | 14,66 | -733 000 | 6 597 000 | |
| 2021-05-11 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -1 066 | 537 160 | -0,20 | 44,84 | -47 803 | 24 087 866 |
| 2021-05-11 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -3 956 | 538 226 | -0,73 | 44,10 | -174 479 | 23 738 458 |
| 2021-05-11 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -36 522 | 542 182 | -6,31 | 43,05 | -1 572 236 | 23 340 393 |
| 2021-05-11 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -8 456 | 578 704 | -1,44 | 42,17 | -356 581 | 24 403 369 |
| 2021-05-11 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 587 160 | 9,31 | 14,66 | 733 000 | 8 607 766 |
| 2021-04-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | -50 000 | 500 000 | -9,09 | 14,66 | -733 000 | 7 330 000 | |
| 2021-04-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -50 000 | 537 160 | -8,52 | 42,54 | -2 127 250 | 22 853 472 |
| 2021-04-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 587 160 | 9,31 | 14,66 | 733 000 | 8 607 766 |
| 2021-03-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | -50 000 | 550 000 | -8,33 | 14,66 | -733 000 | 8 063 000 | |
| 2021-03-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -33 890 | 537 160 | -5,93 | 46,48 | -1 575 112 | 24 965 693 |
| 2021-03-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -16 110 | 571 050 | -2,74 | 45,58 | -734 342 | 26 030 172 |
| 2021-03-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 587 160 | 9,31 | 14,66 | 733 000 | 8 607 766 |
| 2021-02-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | -39 354 | 0 | -100,00 | ||||
| 2021-02-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -19 511 | 537 160 | -3,50 | 48,69 | -949 991 | 26 154 320 | |
| 2021-02-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 39 354 | 556 671 | 7,61 | ||||
| 2021-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
A - Award | 52 368 | 52 368 | |||||
| 2021-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
A - Award | 90 134 | 90 134 | |||||
| 2021-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | -28 729 | 28 729 | -50,00 | ||||
| 2021-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -14 243 | 517 317 | -2,68 | 49,84 | -709 871 | 25 783 079 | |
| 2021-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 28 729 | 531 560 | 5,71 | ||||
| 2021-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | -32 795 | 65 589 | -33,33 | ||||
| 2021-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -16 259 | 502 831 | -3,13 | 49,84 | -810 349 | 25 061 097 | |
| 2021-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 32 795 | 519 090 | 6,74 | ||||
| 2021-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | -31 282 | 93 844 | -25,00 | ||||
| 2021-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -15 509 | 486 295 | -3,09 | 50,60 | -784 755 | 24 606 527 | |
| 2021-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 31 282 | 501 804 | 6,65 | ||||
| 2021-02-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | -50 000 | 600 000 | -7,69 | 14,66 | -733 000 | 8 796 000 | |
| 2021-02-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -5 437 | 470 522 | -1,14 | 48,51 | -263 736 | 22 823 893 |
| 2021-02-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -44 563 | 475 959 | -8,56 | 47,76 | -2 128 182 | 22 730 231 |
| 2021-02-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 520 522 | 10,63 | 14,66 | 733 000 | 7 630 853 |
| 2020-11-30 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
G - Gift | -10 000 | 470 522 | -2,08 | ||||
| 2020-11-25 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | -50 000 | 650 000 | -7,14 | 14,66 | -733 000 | 9 529 000 | |
| 2020-11-25 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | -27 674 | 480 522 | -5,45 | 41,18 | -1 139 643 | 19 788 376 | |
| 2020-11-25 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | -22 326 | 508 196 | -4,21 | 40,17 | -896 925 | 20 416 266 | |
| 2020-11-25 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 50 000 | 530 522 | 10,41 | 14,66 | 733 000 | 7 777 453 | |
| 2020-08-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
G - Gift | -10 000 | 480 522 | -2,04 | ||||
| 2020-05-21 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
A - Award | 1 531 | 4 897 | 45,48 | ||||
| 2020-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | -39 354 | 39 354 | -50,00 | ||||
| 2020-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -19 511 | 490 522 | -3,83 | 21,83 | -425 925 | 10 708 095 | |
| 2020-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 39 354 | 510 033 | 8,36 | ||||
| 2020-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | -28 730 | 57 458 | -33,33 | ||||
| 2020-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -14 244 | 470 679 | -2,94 | 21,10 | -300 548 | 9 931 327 | |
| 2020-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 28 730 | 484 923 | 6,30 | ||||
| 2020-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | -32 795 | 98 384 | -25,00 | ||||
| 2020-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -16 259 | 456 193 | -3,44 | 20,00 | -325 180 | 9 123 860 | |
| 2020-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 32 795 | 472 452 | 7,46 | ||||
| 2020-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
A - Award | 125 126 | 125 126 | |||||
| 2020-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
A - Award | 266 051 | 266 051 | |||||
| 2020-02-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | -55 487 | 0 | -100,00 | ||||
| 2020-02-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | -19 910 | 439 657 | -4,33 | 19,21 | -382 471 | 8 445 811 | |
| 2020-02-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 55 487 | 459 567 | 13,73 | ||||
| 2020-02-04 |
|
5 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
G - Gift | -12 500 | 404 080 | -3,00 | ||||
| 2019-05-16 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
A - Award | 1 722 | 3 366 | 104,74 | ||||
| 2019-02-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | -39 354 | 78 708 | -33,33 | ||||
| 2019-02-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | -19 511 | 416 580 | -4,47 | 16,81 | -327 980 | 7 002 710 | |
| 2019-02-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 39 354 | 436 091 | 9,92 | ||||
| 2019-02-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | -28 730 | 86 188 | -25,00 | ||||
| 2019-02-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | -14 244 | 396 737 | -3,47 | 16,54 | -235 596 | 6 562 030 | |
| 2019-02-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 28 730 | 410 981 | 7,52 | ||||
| 2019-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
A - Award | 131 179 | 131 179 | |||||
| 2019-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock |
A - Award | 250 218 | 250 218 | |||||
| 2019-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | -31 250 | 0 | -100,00 | ||||
| 2019-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | -14 547 | 382 251 | -3,67 | 16,73 | -243 371 | 6 395 059 | |
| 2019-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 31 250 | 396 798 | 8,55 | ||||
| 2019-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | -55 487 | 55 487 | -50,00 | ||||
| 2019-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | -19 425 | 365 548 | -5,05 | 16,12 | -313 131 | 5 892 634 | |
| 2019-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 55 487 | 384 973 | 16,84 | ||||
| 2018-10-03 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy) |
A - Award | 1 298 | 1 298 | |||||
| 2018-07-05 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy) |
A - Award | 1 297 | 1 297 | |||||
| 2018-06-05 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy) |
A - Award | 665 | 665 | |||||
| 2018-05-17 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
A - Award | 1 644 | 1 644 | |||||
| 2018-02-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | -39 354 | 118 062 | -25,00 | ||||
| 2018-02-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | -19 511 | 329 486 | -5,59 | 19,28 | -376 172 | 6 352 490 | |
| 2018-02-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 39 354 | 348 997 | 12,71 | ||||
| 2018-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
A - Award | 114 918 | 114 918 | |||||
| 2018-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock |
A - Award | 201 552 | 201 552 | |||||
| 2018-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | -31 250 | 31 250 | -50,00 | ||||
| 2018-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | -15 493 | 309 643 | -4,77 | 18,25 | -282 747 | 5 650 985 | |
| 2018-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 31 250 | 325 136 | 10,63 | ||||
| 2018-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | -55 487 | 110 974 | -33,33 | ||||
| 2018-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | -24 111 | 293 886 | -7,58 | 18,37 | -442 919 | 5 398 686 | |
| 2018-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 55 487 | 317 997 | 21,14 | ||||
| 2018-01-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | -30 000 | 0 | -100,00 | ||||
| 2018-01-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | -11 649 | 262 510 | -4,25 | 19,46 | -226 690 | 5 108 445 | |
| 2018-01-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 30 000 | 274 159 | 12,29 | ||||
| 2017-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
A - Award | 157 416 | 157 416 | |||||
| 2017-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock |
A - Award | 251 923 | 251 923 | |||||
| 2017-02-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | -31 250 | 62 500 | -33,33 | ||||
| 2017-02-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 31 250 | 244 159 | 14,68 | ||||
| 2017-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | -55 487 | 166 461 | -25,00 | ||||
| 2017-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 55 487 | 212 909 | 35,25 | ||||
| 2017-01-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | -30 000 | 30 000 | -50,00 | ||||
| 2017-01-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 30 000 | 157 422 | 23,54 | ||||
| 2016-09-02 |
|
4 | RLYP |
Relypsa Inc
Stock Option (Right to Buy) |
D - Sale to Issuer | -4 500 | 0 | -100,00 | ||||
| 2016-09-02 |
|
4 | RLYP |
Relypsa Inc
Stock Option (Right to Buy) |
D - Sale to Issuer | -4 500 | 0 | -100,00 | ||||
| 2016-09-02 |
|
4 | RLYP |
Relypsa Inc
Stock Option (Right to Buy) |
D - Sale to Issuer | -12 000 | 0 | -100,00 | ||||
| 2016-09-02 |
|
4 | RLYP |
Relypsa Inc
Common Stock |
D - Sale to Issuer | -2 250 | 0 | -100,00 | 32,00 | -72 000 | ||
| 2016-09-02 |
|
4 | RLYP |
Relypsa Inc
Common Stock |
U - Other | -1 237 | 2 250 | -35,47 | 32,00 | -39 584 | 72 000 | |
| 2016-07-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Performance Stock Units |
M - Exercise | -13 500 | 0 | -100,00 | ||||
| 2016-07-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Performance Stock Units |
A - Award | 13 500 | 13 500 | |||||
| 2016-07-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | -7 044 | 127 422 | -5,24 | 8,63 | -60 790 | 1 099 652 | |
| 2016-07-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 13 500 | 134 466 | 11,16 | ||||
| 2016-06-23 |
|
4 | RLYP |
Relypsa Inc
Stock Option (Right to Buy) |
A - Award | 4 500 | 4 500 | |||||
| 2016-06-23 |
|
4 | RLYP |
Relypsa Inc
Common Stock |
A - Award | 2 250 | 3 487 | 181,89 | ||||
| 2016-06-08 |
|
4 | RLYP |
Relypsa Inc
Common Stock |
S - Sale | -1 013 | 1 237 | -45,02 | 19,32 | -19 570 | 23 897 | |
| 2016-02-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | -31 250 | 93 750 | -25,00 | ||||
| 2016-02-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | -11 743 | 120 966 | -8,85 | 7,90 | -92 770 | 955 631 | |
| 2016-02-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 31 250 | 132 709 | 30,80 | ||||
| 2016-02-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
A - Award | 221 948 | 221 948 | |||||
| 2016-02-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock |
A - Award | 376 569 | 376 569 | |||||
| 2016-01-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | -30 000 | 60 000 | -33,33 | ||||
| 2016-01-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | -11 686 | 101 459 | -10,33 | 15,77 | -184 288 | 1 600 008 | |
| 2016-01-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 30 000 | 113 145 | 36,08 | ||||
| 2016-01-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | -16 436 | 83 145 | -16,51 | 17,33 | -284 836 | 1 440 903 | |
| 2016-01-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
A - Award | 31 500 | 99 581 | 46,27 | ||||
| 2015-06-08 |
|
4 | RLYP |
Relypsa Inc
Stock Option (right to buy) |
A - Award | 4 500 | 4 500 | |||||
| 2015-06-08 |
|
4 | RLYP |
Relypsa Inc
Common Stock |
A - Award | 2 250 | 2 250 | |||||
| 2015-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
A - Award | 125 000 | 125 000 | |||||
| 2015-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock |
A - Award | 200 000 | 200 000 | |||||
| 2015-01-26 |
|
4 | RLYP |
Relypsa Inc
Stock Option (right to buy) |
A - Award | 12 000 | 12 000 | |||||
| 2015-01-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | -30 000 | 90 000 | -25,00 | ||||
| 2015-01-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | -11 919 | 68 081 | -14,90 | 10,06 | -119 905 | 684 895 | |
| 2015-01-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 30 000 | 80 000 | 60,00 | ||||
| 2014-09-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 50 000 | 50 000 | 8,92 | 446 000 | 446 000 | ||
| 2014-01-08 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
A - Award | 120 000 | 120 000 | |||||
| 2014-01-08 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock |
A - Award | 700 000 | 700 000 | 14,66 | 10 262 000 | 10 262 000 | ||
| 2014-01-08 | 3 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
0 | ||||||||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | -24 300 | 0 | -100,00 | ||||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | -12 156 | 0 | -100,00 | ||||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | -1 144 | 0 | -100,00 | ||||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | -44 132 | 0 | -100,00 | ||||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | -11 868 | 0 | -100,00 | ||||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | -28 575 | 0 | -100,00 | 125,00 | -3 571 875 | ||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
U - Other | -7 336 | 28 575 | -20,43 | 125,00 | -917 000 | 3 571 875 | |
| 2013-09-05 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | -2 099 | 35 911 | -5,52 | 123,62 | -259 478 | 4 439 318 |
| 2013-08-14 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -1 250 | 13 300 | -8,59 | ||||
| 2013-08-14 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -7 000 | 56 000 | -11,11 | ||||
| 2013-08-14 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 061 | 46 585 | -2,23 | 126,92 | -134 667 | 5 912 801 |
| 2013-08-14 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -8 250 | 47 646 | -14,76 | 126,89 | -1 046 810 | 6 045 615 |
| 2013-08-14 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 250 | 55 896 | 2,29 | 37,68 | 47 100 | 2 106 161 | |
| 2013-08-14 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 000 | 54 646 | 14,69 | 33,70 | 235 900 | 1 841 570 | |
| 2013-05-15 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -1 250 | 14 450 | -7,96 | ||||
| 2013-05-15 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -7 000 | 63 000 | -10,00 | ||||
| 2013-05-15 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 000 | 47 646 | -2,06 | 97,26 | -97 260 | 4 634 055 |
| 2013-05-15 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 500 | 48 646 | -4,89 | 98,28 | -245 690 | 4 780 739 |
| 2013-05-15 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 000 | 51 146 | -5,54 | 98,78 | -296 352 | 5 052 406 |
| 2013-05-15 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 750 | 54 146 | -3,13 | 97,32 | -170 308 | 5 269 413 |
| 2013-05-15 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 000 | 55 896 | 14,32 | 33,70 | 235 900 | 1 883 695 | |
| 2013-05-15 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 250 | 48 896 | 2,62 | 37,68 | 47 100 | 1 842 401 | |
| 2013-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -466 | 47 646 | -0,97 | 86,14 | -40 141 | 4 104 226 |
| 2013-04-01 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 24 300 | 24 300 | |||||
| 2013-04-01 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
A - Award | 8 600 | 48 112 | 21,77 | ||||
| 2013-02-06 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -1 250 | 15 800 | -7,33 | ||||
| 2013-02-06 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -7 000 | 70 000 | -9,09 | ||||
| 2013-02-06 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -8 250 | 39 512 | -17,27 | 78,61 | -648 532 | 3 106 038 |
| 2013-02-06 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 250 | 47 762 | 2,69 | 37,68 | 47 100 | 1 799 672 | |
| 2013-02-06 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 000 | 46 512 | 17,72 | 33,70 | 235 900 | 1 567 454 | |
| 2012-11-30 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -1 250 | 17 050 | -6,83 | ||||
| 2012-11-30 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -7 000 | 77 000 | -8,33 | ||||
| 2012-11-30 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -11 997 | 39 512 | -23,29 | 75,22 | -902 414 | 2 972 093 |
| 2012-11-30 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 250 | 51 509 | 2,49 | 37,68 | 47 100 | 1 940 859 | |
| 2012-11-30 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 000 | 50 259 | 16,18 | 33,70 | 235 900 | 1 693 728 | |
| 2012-10-05 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 314 | 43 259 | -5,08 | 86,51 | -200 184 | 3 742 336 |
| 2012-09-06 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 878 | 56 823 | -3,20 | 72,78 | -136 681 | 4 135 578 |
| 2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 000 | 58 701 | -3,29 | 71,89 | -143 780 | 4 220 015 | |
| 2012-07-27 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -4 549 | 60 701 | -6,97 | 73,97 | -336 498 | 4 490 168 |
| 2012-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 18 300 | 18 300 | |||||
| 2012-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
A - Award | 17 150 | 65 250 | 35,65 | ||||
| 2012-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
A - Award | 3 600 | 48 100 | 8,09 |
